13. Disparities in the risk and outcomes of COVID-19. London: Public Health England; 2
June 2020 (https://www.gov.uk/government/publications/covid-19-review-of-
disparities-in-risks-and-outcomes, accessed 14 October 2020).
14. Lassale C, Gaye B, Hamer M, et al. Ethnic disparities in hospitalization for COVID-19: a
community-based cohort study in the UK [preprint]. medRxiv.
doi:https://doi.org/10.1101/2020.05.19.20106344.
15. Kaul P. India’s stark inequalities make social distancing much easier for some than
others. The Conversation. 2 April 2020 (https://theconversation.com/indias-stark-
inequalities-make-social-distancing-much-easier-for-some-than-others-134864,
accessed 14 October 2020).
16. Hatcher SM, Agnew-Brune C, Anderson M, et al. COVID-19 Among American Indian and
Alaska Native Persons — 23 States, January 31–July 3, 2020. MMWR Morb Mortal Wkly
Rep 2020;69:1166–1169.
doi:http://dx.doi.org/10.15585/mmwr.mm6934e1
17. Sumaili EK, Cohen EP, Zinga CV, et al. High prevalence of undiagnosed chronic kidney
disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC
Nephrol. 2009; 10(1):18.
doi:https://doi.org/10.1186/1471-2369-10-18.
18. Fallah MP, Skrip LA, Gertler S, et al. Quantifying poverty as a driver of Ebola
transmission. PLoS Negl Trop Dis. 2015; 9(12):e0004260.
doi:https://doi.org/10.1371/journal.pntd.0004260.
19. The Sustainable Development Goals report 2020. New York (NY): United Nations; 2020
(https://unstats.un.org/sdgs/report/2020/, accessed 14 October 2020).
20. Wasdani KP, Prasad A. The impossibility of social distancing among the urban poor: the
case of an Indian slum in the times of COVID-19. Local Environ. 3 May 2020; 25(5):414–
8. doi:10.1080/13549839.2020.1754375.
21. Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the
population at increased risk of severe COVID-19 due to underlying health conditions in
2020: a modelling study. Lancet Glob Health. 1 August 2020; 8(8):e1003–17.
doi:https://doi.org/10.1016/S2214-109X(20)30264-3.
22. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal
and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic
review and meta-analysis. BMJ. 1 September 2020; 370.
doi:https://doi.org/10.1136/bmj.m3320.
23. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with
laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States,
January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep. 26 June 2020; 69(25):769.
doi:http://dx.doi.org/10.15585/mmwr.mm6925a1.
24. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth
outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 —
COVID-NET, 13 States, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 25
September 2020; 69(38):1347–1354.
doi:http://dx.doi.org/10.15585/mmwr.mm6938e1.
25. PAHO/WHO. Epidemiological update: coronavirus disease (COVID-19). Washington
(DC): Pan American Health Organization/World Health Organization; 18 September
2020.
26. Krubiner CB, Faden RR, Karron RA, et al. Pregnant women & vaccines against emerging
epidemic threats: ethics guidance for preparedness, research, and response. Vaccine.
2019. doi:https://doi.org/10.1016/j.vaccine.2019.01.011.